120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
青蒿舌下免疫治疗季节性过敏性鼻炎的疗效及其与花粉暴露变化的关系：一项多中心研究
Authors Liu S, Li J, Zhang X, Ma T, Liu Y, Zhang Y , Zhang L , Wang C
Received 14 September 2025
Accepted for publication 19 January 2026
Published 10 February 2026 Volume 2026:19 567425
DOI https://doi.org/10.2147/JAA.S567425
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Dr Luis Garcia-Marcos
Shixian Liu,1– 4,* Jingyun Li,1,3,4,* Xu Zhang,2 Tingting Ma,5 Yan Liu,6 Yuan Zhang,2 Luo Zhang,1– 4 Chengshuo Wang1– 4
1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, People’s Republic of China; 3Beijing Institute of Otolaryngology, Beijing Laboratory of Allergic Diseases, Beijing Key Laboratory of Nasal Diseases, Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Capital Medical University, Beijing, People’s Republic of China; 4Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 5Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 6Department of Otorhinolaryngology, Head and Neck Surgery, Peking University People’s Hospital, Beijing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Chengshuo Wang, Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, No. 17, Hougouhutong, DongCheng District, Beijing, 100005, People’s Republic of China, Tel +8610 58268375; +8613911623569, Fax +8610 85115988, Email wangcs830@126.com Luo Zhang, Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, No. 1, DongJiaoMinXiang, DongCheng District, Beijing, 100730, People’s Republic of China, Tel +8610 58265719; +86 13910830399, Fax +8610 85115988, Email dr.luozhang@139.com
Purpose: Evaluating allergen immunotherapy efficacy amidst natural pollen fluctuations is complicated by pollen variation. This study evaluates the relationship between pollen exposure and therapeutic impact of Artemisia annua sublingual immunotherapy (SLIT) in seasonal allergic rhinitis (SAR).
Patients and Methods: In a two-year multicenter, controlled trial, SAR patients sensitized to Artemisia received SLIT or symptomatic medication. Daily assessments of combined symptom and medication score (CSMS), total nasal symptom score (TNSS) and daily medication score (DMS), were conducted across two pollen seasons. Linear mixed-effect models (LMMs) were utilized to evaluate treatment effects while considering pollen variability. Exploratory analyses of immunoglobulins in serum and nasal secretions were performed.
Results: Pollen fluctuations correlated positively with CSMS, TNSS, and DMS in both groups. SLIT significantly reduced the mean daily CSMS (β = − 0.34, q < 0.001), TNSS (β = − 1.01, q < 0.001), and DMS (β = − 0.09, q < 0.001) compared to the control group. These effects were consistent across both pollen seasons. During the first pollen season, a significantly negative impact of group × time × pollen interactions on the average daily CSMS was observed in SLIT group (β = − 0.11, P = 0.03). LMM analyses revealed significant group × time interactions for serum Artemisia-specific IgG4 and IgA with nasal IgA showing isolated significance.
Conclusion: SLIT provided early and sustained symptom relief in SAR, taking into account the annual and seasonal pollen fluctuations. SLIT efficacy may be influenced by pollen exposure, with effect size increasing in correlation with higher levels of pollen exposure. SLIT elevated allergen-specific IgG4 and IgA in systemic and local compartments.
Keywords: seasonal allergic rhinitis, sublingual immunotherapy, pollen exposure, symptom severity, efficacy
1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, People’s Republic of China; 3Beijing Institute of Otolaryngology, Beijing Laboratory of Allergic Diseases, Beijing Key Laboratory of Nasal Diseases, Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Capital Medical University, Beijing, People’s Republic of China; 4Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 5Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 6Department of Otorhinolaryngology, Head and Neck Surgery, Peking University People’s Hospital, Beijing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Chengshuo Wang, Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, No. 17, Hougouhutong, DongCheng District, Beijing, 100005, People’s Republic of China, Tel +8610 58268375; +8613911623569, Fax +8610 85115988, Email wangcs830@126.com Luo Zhang, Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, No. 1, DongJiaoMinXiang, DongCheng District, Beijing, 100730, People’s Republic of China, Tel +8610 58265719; +86 13910830399, Fax +8610 85115988, Email dr.luozhang@139.com
Purpose: Evaluating allergen immunotherapy efficacy amidst natural pollen fluctuations is complicated by pollen variation. This study evaluates the relationship between pollen exposure and therapeutic impact of Artemisia annua sublingual immunotherapy (SLIT) in seasonal allergic rhinitis (SAR).
Patients and Methods: In a two-year multicenter, controlled trial, SAR patients sensitized to Artemisia received SLIT or symptomatic medication. Daily assessments of combined symptom and medication score (CSMS), total nasal symptom score (TNSS) and daily medication score (DMS), were conducted across two pollen seasons. Linear mixed-effect models (LMMs) were utilized to evaluate treatment effects while considering pollen variability. Exploratory analyses of immunoglobulins in serum and nasal secretions were performed.
Results: Pollen fluctuations correlated positively with CSMS, TNSS, and DMS in both groups. SLIT significantly reduced the mean daily CSMS (β = − 0.34, q < 0.001), TNSS (β = − 1.01, q < 0.001), and DMS (β = − 0.09, q < 0.001) compared to the control group. These effects were consistent across both pollen seasons. During the first pollen season, a significantly negative impact of group × time × pollen interactions on the average daily CSMS was observed in SLIT group (β = − 0.11, P = 0.03). LMM analyses revealed significant group × time interactions for serum Artemisia-specific IgG4 and IgA with nasal IgA showing isolated significance.
Conclusion: SLIT provided early and sustained symptom relief in SAR, taking into account the annual and seasonal pollen fluctuations. SLIT efficacy may be influenced by pollen exposure, with effect size increasing in correlation with higher levels of pollen exposure. SLIT elevated allergen-specific IgG4 and IgA in systemic and local compartments.
Keywords: seasonal allergic rhinitis, sublingual immunotherapy, pollen exposure, symptom severity, efficacy